Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/15670652

Neurosci. Lett. 2005 Feb 28 375 2 112-6

Download in:

View as

General Info

PMID
15670652